Curative Biotechnology Overview
Curative Biotechnology (CUBT) has a ROE of 41.84%, above the sector sector average of -5.87%.
Get informed when a big investor buys or sells
+ Follow41.84%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, CUBT shows a ROE of 41.84%. That is above the sector sector average of -5.87%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about -5.87%. Curative Biotechnology is at 41.84%, which is higher that average. That is roughly 812.9% above the sector mean. Use the comparison chart on this page to see how CUBT stacks up against individual peers as well.
Check the historical chart to see whether CUBT's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Curative Biotechnology with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Curative Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 41.84%) with ownership activity and broader fundamentals.
